Healthcare Sector

GSK

Market Tracker

$52.28
+0.29
(+0.56%)
12:14 am
Next Earnings: (est.) 02/04/17 12:00 am
  • GSK (Selected)

    GlaxoSmithKline plc
  • GSKY

    GreenSky, Inc.

GSK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

GSK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

GSK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

GSK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

GSK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

GSK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
04/10/2026 CALL $57.00 161 +158 +5,266.67%
04/17/2026 CALL $53.00 83 +83
03/27/2026 CALL $55.00 84 +55 +189.66%
11/20/2026 CALL $55.00 52 +52
03/27/2026 CALL $54.00 53 +37 +231.25%
11/20/2026 PUT $35.00 30 +30
11/20/2026 PUT $40.00 0 -1 -100.00%
04/02/2026 PUT $54.00 15 -3 -16.67%
03/27/2026 CALL $63.00 80 -4 -4.76%
06/18/2026 CALL $50.00 445 -5 -1.11%
04/24/2026 CALL $53.00 11 -5 -31.25%
11/20/2026 CALL $65.00 9 -7 -43.75%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

GSK Major Holders

Name Pct Held Shares Total
Dodge & Cox Stock Fund 2.22% 45.46M 1.57B
Dodge & Cox Balanced Fund 0.29% 5.99M 206.79M
Price (T.Rowe) International Value Equity Fund 0.16% 3.28M 113.2M
Vanguard/Primecap Fund 0.15% 3.01M 103.97M
Price (T.Rowe) International Value Equity Trust 0.14% 2.86M 98.7M
Fidelity Series Large Cap Stock Fund 0.14% 2.84M 97.98M
Price (T.Rowe) Overseas Stock Fund 0.13% 2.64M 91.02M
American Mutual Fund Inc 0.08% 1.74M 59.98M
Fidelity Growth & Income Portfolio 0.08% 1.6M 55.17M
Vanguard/Windsor II 0.08% 1.57M 54.09M

GSK News

  • Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

    03/16 07:19 am

    Benzinga

    Read more
  • BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon

    03/16 06:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Broadens Access To GSK's Respiratory Syncytial Virus Shot For Younger High-Risk Adults

    03/13 12:33 pm

    Benzinga

    Read more
  • Herpes Zoster Market Poised for Robust Growth During the Forecast Period (2026–2036) Driven by Rising Incidence and Vaccine Adoption | DelveInsight

    03/09 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Infanrix and Infanrix-hexa Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/09 10:58 am

    GlobeNewswire Inc.

    Read more
  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

    03/02 05:59 am

    GlobeNewswire Inc.

    Read more
  • Deal Dispatch: Funko For Sale? Caesars Casino Weighs Offers, iPic Bankrupt

    02/27 05:05 pm

    Benzinga

    Read more
  • GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play

    02/25 08:22 am

    Benzinga

    Read more
  • 35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)

    02/25 03:00 am

    Benzinga

    Read more
  • Anti-snoring Devices Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations and Launches, Sustainability Goals, Revenue Insights

    02/24 08:00 am

    GlobeNewswire Inc.

    Read more
  • Sexual Health Supplement Market Report 2026-2035: Market to Reach $5.31 Billion by 2030, Driven by Biotechnology Innovation, Transparency in Ingredient Traceability and Gender-Specific Expansion

    02/20 06:49 am

    GlobeNewswire Inc.

    Read more
  • Epstein Scandal Spreads In Europe, Fueling UK Political Crisis And Gilt Market Shock

    02/19 10:49 am

    Benzinga

    Read more
  • Merck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use

    02/19 08:56 am

    Benzinga

    Read more
  • Europe Clears GSK's New Twice-Yearly Asthma Treatment

    02/17 07:31 am

    Benzinga

    Read more
  • Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider

    02/16 09:00 am

    GlobeNewswire Inc.

    Read more
  • Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

    02/06 06:00 am

    GlobeNewswire Inc.

    Read more
  • Teeth Whitening Products Market to Reach US$ 8.73 Billion by 2031 Driven by Rising Aesthetic Awareness, Social Media Influence, and Rapid Adoption of At-Home Whitening Solutions | Astute Analytica

    02/05 02:41 pm

    GlobeNewswire Inc.

    Read more
  • Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

    02/05 04:57 am

    GlobeNewswire Inc.

    Read more
  • GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike

    02/04 09:12 am

    Benzinga

    Read more
  • Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path

    02/02 03:16 pm

    Benzinga

    Read more
  • Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

    01/28 06:51 am

    Benzinga

    Read more
  • Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

    01/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA

    01/27 08:00 am

    GlobeNewswire Inc.

    Read more
  • Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider

    01/22 12:00 pm

    GlobeNewswire Inc.

    Read more
  • High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

    01/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Rapt Therapeutics Stock Soared Today

    01/20 06:10 pm

    The Motley Fool

    Read more
  • $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)

    01/20 03:34 pm

    Benzinga

    Read more
  • Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK

    01/20 03:13 pm

    Benzinga

    Read more
  • GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough

    01/20 06:54 am

    Benzinga

    Read more
  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

    01/08 07:00 pm

    GlobeNewswire Inc.

    Read more
  • GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies

    01/07 12:48 pm

    Benzinga

    Read more
  • Sitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications

    01/06 08:00 am

    GlobeNewswire Inc.

    Read more
  • Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

    12/31 09:59 am

    Benzinga

    Read more
  • Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out

    12/19 01:43 pm

    Benzinga

    Read more
  • FDA Approves GSK's Drug, Targets Severe Asthma With Two Doses Per Year

    12/17 10:04 am

    Benzinga

    Read more
  • GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients

    12/12 12:12 pm

    Benzinga

    Read more
  • Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

    12/10 03:00 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

    12/03 01:24 pm

    Benzinga

    Read more
  • Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    11/28 09:00 am

    GlobeNewswire Inc.

    Read more
  • Asthma and COPD Medicines Market Size to Lead USD 19.32 Bn by 2035

    11/26 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight

    11/24 02:00 pm

    GlobeNewswire Inc.

    Read more
  • GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties

    11/21 09:48 am

    Benzinga

    Read more
  • Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

    11/21 04:50 am

    GlobeNewswire Inc.

    Read more
  • SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK

    11/19 08:00 am

    GlobeNewswire Inc.

    Read more
  • IMU Biosciences announces formation of Scientific Advisory Board

    11/13 04:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: